Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: POLBF )

0.1150 UNCHANGED
Last Price Updated: 9:30 AM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1150
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1150
Today's Range 0.1150 - 0.1150
52wk Range 0.1001 - 0.1050
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Poolbeg Pharma PLC Announces Favourable Conclusion of Patent Opposition
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Immunomodulator I Patent Opposition Withdrawal
Via ACCESSWIRE

Performance

YTD
+14.89%
+14.89%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+43.93%
+43.93%

More News

Read More
Poolbeg Pharma "moving forward rapidly" with POLB001
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
Poolbeg Pharma "moving forward rapidly" with POLB001
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Poolbeg Pharma PLC Announces Interim Results for the Six Months to 30 June 2023
Via ACCESSWIRE
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"
Via News Direct
Topics Artificial Intelligence
Exposures Artificial Intelligence
Poolbeg Pharma PLC Announces AI Led Programme Identifies Influenza Drug Targets
Via ACCESSWIRE
Poolbeg Pharma PLC - Oral Vaccine Programme Moves Forward
Via ACCESSWIRE
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"
Via TheNewswire.com
Topics Artificial Intelligence
Exposures Artificial Intelligence
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines
Via News Direct
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines
Via TheNewswire.com
Poolbeg Pharma PLC Announces Annual Report & AGM Notice
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Board Appointment
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Results of Annual General Meeting
Via ACCESSWIRE
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
Via News Direct
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
Via TheNewswire.com
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
Via News Direct
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
Via TheNewswire.com
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
Via News Direct
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
Via TheNewswire.com
Poolbeg Pharma "really open" to different types of deal for POLB 001
Via News Direct
Poolbeg Pharma "really open" to different types of deal for POLB 001
Via TheNewswire.com
Poolbeg Pharma announces expansion of POLB 001 into oncology
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Poolbeg Pharma announces expansion of POLB 001 into oncology
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.